Publications


2022

2021

Chemonges, CC, Joshua N, Granai M, Lazzi S, Ndungu JR, Leoncini L.  2021.  A review of the sub-classification of lymph node biopsies reported as reactive lymphadenitis at Kenyatta National Hospital, Kenya.. Int. J Pathol Clin Res. . 7(1):120.

2020

Mundo, L, Porro LD, Granai M, Siciliano MC, Mancini V, Santi R, Marcar L, Vrzalikova K, Vergoni F, Stefano GD, Schivoni G, Segreto G, Noel Onyango, Nyagol JA, Amato T, Bellan C, Anagnostopoulos I, Falini B, Leoncini L, Lazzi S.  2020.  Correction: Frequent traces of EBV infection in Hodgkin and non-Hodgkin lymphomas classified as EBV-negative by routine methods: expanding the landscape of EBV-related lymphomas.. Modern Pathology. :10.1038/s41379-020-0608-y..
Mundo, L, Porro LD, Granai M, Siciliano MC, Mancini V, Santi R, Marcar L, Vrzalikova K, Vergoni F, Stefano GD, Schivoni G, Segreto G, Noel Onyango, Nyagol JA, Amato T, Bellan C, Anagnostopoulos I, Falini B, Leoncini L, Lazzi S.  2020.  Frequent traces of EBV infection in Hodgkin and non-Hodgkin lymphomas classified as EBV-negative by routine methods: expanding the landscape of EBV-related lymphomas.. Modern Pathology .
M, G, L M, AU A, MC S, H R, V M, N O, J N, OA A, I M, S M, W W, M B, PP P, L Q-M, F F, S L, Leoncini L, T M.  2020.  Correction: Immune landscape in Burkitt lymphoma reveals M2-macrophage polarization and correlation between PD-L1 expression and non-canonical EBV latency program. . Infect Agent & Cancer . 15(39):doi:10.1186/s13027-020-00304-9..
M, G, L M, AU A, MC S, H R, V M, N O, J N, OA A, I M, S M, W W, M B, PP P, L Q-M, F F, S L, Leoncini L, T M.  2020.  Immune landscape in Burkitt lymphoma reveals M2-macrophage polarization and correlation between PD-L1 expression and non-canonical EBV latency program. . Infectious Agents & Cancer . 15(28)

2019

Mundo, L, Ambrosio M, Raimondi F, Porro LD, Granai M, Mancini V, Guazzo R, Rocca B, Lopez C, Bens S, Noel Onyango, Joshua Nyagol, Abinya N, Navari M, Ndede I, Patel K, Piccaluga PP, Bob R, Santi MD, Russel R, Lazzi S, Siebert R, Stein H, Leoncini L.  2019.  Molecular switch from MYC to MYCN expression in MYC protein negative Burkitt lymphoma cases.. Blood Cancer Journal. . 9(91):2-10.
M, M, LZ M, J F, GM E, E R, R N, J T, DH M, J N, F W, AK B, M B, JG. O.  2019.  Kaposi Sarcoma-associated Herpesvirus Glycoprotein H is Indispensable for Infection of Epithelial, Endothelial, and Fibroblast Cell Types. . J Virol. . 93(16)

2018

2017

2016

2015

EK, R, J N, J O, S N, N O, A O, CJ S, G B, WC C, B O, B E.  2015.  The effects of HIV-1 infection on malaria parasitemia in milo sub-location, western Kenya.. BMC Res Notes.. 8:303.

2014

A, M, J N, Rogena E, W O, Kimani M, N O, L P, R S, Leoncini L, W M.  2014.  Correlation of EGFR, pEGFR and p16INK4 expressions and high-risk HPV infection in HIV/AIDS-related squamous cell carcinoma of conjunctiva.. Infect Agent Cancer. . 9(1):7.

2013

Nyagol, J, Kisato V, Ochuk W, Wakio M.  2013.  Assessment of hormonal receptors and Her-2/neu status in breast cancer using cell block: a case study. . J. Afr. Cancer.. 5:180-184.

2011

Lenze, D, Leoncini L, Hummel M, Volinia S, Liu CG, Amato T, Falco DG, Githanga J, Horn H, Nyagol J, Ott G, Palatini J, Pfreundschuh M, Rogena E, Rosenwald A, Siebert R, Croce CM, Stein H.  2011.  The different epidemiologic subtypes of Burkitt lymphoma share a homogenous micro RNA profile distinct from diffuse large B-cell lymphoma.. Leukemia. :1-8.

2010

E, L, A O, M C, V C, G C, S M, R C, J N, W M, R I, K S, C B, Leoncini L.  2010.  B cell differentiation in EBV-positive Burkitt Lymphoma is impaired at post-transcriptional level by miRNA altered expression. . Int J. Cancer.. 126(6):1316-26.

2008

E, L, M C, A O, van P C, C B, van A R, G DF, J N, B B, S L, P T, van J K, Leoncini L.  2008.  MYC-negative classical Burkitt’s Lymphoma cases: an alternative pathogenetic mechanism involving miRNA deregulation.. J Pathol. . 216(4):440-50.
Falco, DG, Cerino G, Leucci E, Nyagol J, Cocco M, Onnis A, Tosi P, Giordano A, Leoncini L.  2008.  Role of chromatin remodelling mediated by the HIV-1 Tat protein in the genesis of the HIV-1-associated malignancies.. Virchows Archives. 452(S43)

2007

G, DF, E L, D L, PP P, PP C, A O, G C, J N, W M, C B, M H, S P, P T, H S, A G, Leoncini L.  2007.  Gene expression analysis identifies novel RBL2/p130 target genes in endemic Burkitt's lymphoma cell lines and primary tumors. Blood.. 110(4):1301-7.
Leucci, E, Cocco M, Cleef PV, Bellan C, Rijik AV, Falco GD, Onnis A, Joshua Nyagol, Byakika B, Lazzi S, Tosi P, Kricken HV, Leoncini L.  2007.  Altered expression of mirnas in c-MYC negative Burkitt lymphoma cases.. Virchows Archives. 451(2):119.
J., N.  2007.  Oncogenic and Angiogenic Roles of HIV-1 Tat Protein. , Siena, Italy: PhD Thesis, University of Siena

2006

J, N, E L, A O, G DF, C T, F S, M T, N P, L P, R S, D S, P G, L M, S L, F P, Leoncini L, A G.  2006.  The Effects of HIV-1 Tat Protein on Cell Cycle during Cervical Carcinogenesis. Cancer Biol Ther. . 5(6):684-90.
J, N, A N’o, B B, L M, M C, de MM S, D S, C B, S L, I K, P L, Leoncini L.  2006.  Routine assessment of hormonal receptor and Her-2/neu status underscores the need for more therapeutic targets in Kenyan women with breast cancer. J. of AQCH . 28(2):97-103.

2005

C, B, S L, M H, N P, de M S, T A, J N, E S, T L, SA P, M R, H S, P T, Leoncini L.  2005.  Immunoglobulin gene analysis reveals two distinct cells of origin for EBV-positive and EBV-negative Burkitt lymphomas. Blood. 106(3):1031-6.

UoN Websites Search